More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$557741017
EPS
0.33
P/E ratio
56.9
Price to sales
8.62
Dividend yield
--
Beta
0.919477
Previous close
$9.54
Today's open
$9.55
Day's range
$9.48 - $10.01
52 week range
$3.08 - $16.15
show more
CEO
Mark R. Newcomer
Employees
226
Headquarters
Henderson, NV
Exchange
NASDAQ Capital Market
Shares outstanding
56854334
Issue type
Common Stock
Finance
Diversified Financial Services
Paysign: 3 Key Takeaways for Long-Term Investors
Pharma patient affordability revenue grew 110% year-over-year to $16.6 million. Losing 113 plasma centers reduces fourth-quarter revenue by $1.5 million.
The Motley Fool • Nov 15, 2026

Down 39.2% in 4 Weeks, Here's Why Paysign (PAYS) Looks Ripe for a Turnaround
Paysign (PAYS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Zacks Investment Research • Nov 13, 2026

All You Need to Know About Paysign (PAYS) Rating Upgrade to Buy
Paysign (PAYS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks Investment Research • Nov 13, 2026

Is Paysign (PAYS) a Solid Growth Stock? 3 Reasons to Think "Yes"
Paysign (PAYS) possesses solid growth attributes, which could help it handily outperform the market.
Zacks Investment Research • Nov 13, 2026

Paysign's Post-Q3 Selloff Opens An Opportunity
Paysign is rated a Buy at $10 despite losing a major plasma customer, as the selloff is seen as exaggerated. The Pharma segment now drives over half of revenue, growing 110% with higher margins and a larger TAM, offsetting plasma center losses. Management raised guidance for revenue, gross margin, net income, and EBITDA, projecting continued growth and margin expansion into FY26.
Seeking Alpha • Nov 12, 2026

Paysign Q3 Earnings Call Highlights
Paysign NASDAQ: PAYS reported record third-quarter revenue, operating income and adjusted EBITDA as growth in its patient affordability business more than offset slower growth in plasma payment processing.
MarketBeat • Nov 10, 2026

Paysign, Inc. (PAYS) Q3 2026 Earnings Call Transcript
Paysign, Inc. (PAYS) Q3 2026 Earnings Call Transcript
Seeking Alpha • Nov 10, 2026

Paysign Reports Record Third Quarter 2026 Revenue of $30.8 Million, Up 43%; Operating Margin More Than Triples to 23.8%
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ: PAYS), a provider of patient affordability offerings, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced financial results for the third quarter 2026. Third Quarter 2026 Financial Highlights Revenues of $30.80 million in Q3'26, up 42.6% from Q3'25 Pharma revenue increased 109.8% to $16.62 million in Q3'26 versus Q3'25; added 62 net patient a.
Business Wire • Nov 9, 2026

Post-Election Hidden Gems: 3 Under-The-Radar Growth Stocks
Favorable post-midterm election momentum, plus annual market seasonality accelerating with Black Friday, could provide powerful tailwinds for equities. Meanwhile, extreme market fear and macroeconomic uncertainty can create attractive buying opportunities in under-the-radar technology companies with strong fundamentals and exceptional long-term growth potential. In this environment, it's important to remain selective, consider company-specific risks, and evaluate appropriate entry points and long-term portfolio allocations.
Seeking Alpha • Nov 5, 2026

Fintech Leader Vaults 203% To Highs: Earnings On Deck
Fintech stock Paysign scores a new high Friday with a year-to-date gain of 203%. Paysign provides finance tools for several industries.
Investors Business Daily • Oct 16, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Paysign Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.